Lancet Oncology

Orthopaedic revolution
pp. 69-69(1)
Author: The Lancet Oncology

Fragile sites and cancer genes on the short arm of chromosome 8
pp. 77-77(1)
Author: Popescu N.C.

Author's reply
pp. 77-77(1)
Authors: Birnbaum D.; Chaffanet M.

HRPT2 and parathyroid cancer
pp. 78-78(1)
Authors: Marsh D.J.; Morreau H.; Teh B.T.

Erratum
pp. 78-78(1)

Circulating tumour cells in breast cancer
pp. 79-88(10)
Authors: Ring A.; Smith I.E.; Dowsett M.

Genomics-based hypothesis generation: a novel approach to unravelling drug resistance in brain tumours?
pp. 89-100(12)
Authors: Bredel M.; Bredel C.; Sikic B.I.

Small-animal imaging of tumour proliferation with PET
pp. 100-100(1)
Authors: Barthel H.; Price P.; Aboagye E.O.

Active surveillance: towards a new paradigm in the management of early prostate cancer
pp. 101-106(6)
Author: Parker C.

Uncommon primary mediastinal tumours
pp. 107-118(12)
Authors: Macchiarini P.; Ostertag H.

Explanatory models of and attitudes towards cancer in different cultures
pp. 119-124(6)
Author: Dein S.

Haploidentical, non-myeloablative stem-cell transplantation for advanced renal-cell carcinoma
pp. 125-126(2)
Authors: Satoh M.; Miyamura K.; Yamada M.; Ishidoya S.; Childs R.W.; Arai Y.

Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma
pp. 127-128(2)
Authors: Liso A.; Tiacci E.; Binazzi R.; Pulford K.; Benedetti R.; Carotti A.; Aversa F.; Falini B.

Clinical trials with moving targets: a commentary on a non-inferiority trial in testicular cancer
pp. 129-132(4)
Authors: Cullen M.; Stenning S.

Expression Profiling of Human Tumors: Diagnostic and Research Applications
pp. 133-133(1)
Authors: Datar R.H.; Cote R.J.

Top 10 bestsellers
pp. 133-133(1)

Accidents will happen
pp. 134-134(1)
Author: Lee J.A.